Currently out of the existing stock ratings of Jason Cassorla, 64 are a BUY (82.05%), 14 are a HOLD (17.95%).

Jason Cassorla

Work Performance Price Targets & Ratings Chart

Analyst Jason Cassorla, currently employed at GUGGENHEIM, carries an average stock price target met ratio of 37.19% that have a potential upside of 21.93% achieved within 150 days. Previously, Jason Cassorla worked at CITI.

Jason Cassorla’s has documented 147 price targets and ratings displayed on 17 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on THC, Tenet Healthcare at 29-Oct-2025.

Wall Street Analyst Jason Cassorla

Analyst best performing recommendations are on CANO (CANO HEALTH).
The best stock recommendation documented was for CANO (CANO HEALTH) at 8/10/2022. The price target of $7 was fulfilled within 14 days with a profit of $2.26 (47.68%) receiving and performance score of 34.06.

Average potential price target upside

of $48.27 (21.2%) on HCA (HCA HOLDINGS).
of $29.4 (19.96%) on UHS (UNIVERSAL HEALTH SERVICES).
of $27.57 (33.84%) on THC (TENET HEALTHCARE).

AGTI Agiliti BHG Bright Health Group CANO Cano Health CYH Community Health Systems HCA HCA Holdings SGRY Surgery Partners THC Tenet Healthcare CLOV Clover Health Investments Corp UHS Universal Health Services EHAB Enhabit INNV InnovAge Holding Corp PACS PACS Group ACHC Acadia Healthcare Company CI Cigna Corp CNC Centene Corp ELV Elevance Health HUM Humana

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

John Ransom (RAYMOND JAMES)